Patients’ perspectives after switching from infliximab to biosimilar CT-P13 in patients with inflammatory bowel disease: A 12-month prospective cohort study

Nicolas Petitdidier (1) , Jenny Tannoury (1) , Nicola De’angelis (1) , Charlotte Gagniere (1) , Anne Hulin (1) , Hugo Rotkopf (1) , Farida Mesli (1) , Francesco Brunetti (1) , Iradj Sobhani (1) , Aurelien Amiot (1)

1 EC2M3 - Early detection of Colon Cancer using Molecular Markers and Microbiota (EA 7375)

Domaines: Sciences du Vivant [q-bio]

Nicolas Petitdidier, Jenny Tannoury, Nicola De’angelis, Charlotte Gagniere, Anne Hulin, et al.. Patients’ perspectives after switching from infliximab to biosimilar CT-P13 in patients with inflammatory bowel disease: A 12-month prospective cohort study. Digestive and Liver Disease, 2019, 51, pp.1652 - 1660. ⟨10.1016/j.dld.2019.08.020⟩. ⟨hal-03489097⟩